论文信息 - RE: Immune checkpoint profiles in luminal B breast cancer (Alliance). - 字舞流文

RE: Immune checkpoint profiles in luminal B breast cancer (Alliance).

M. Campone | P. Juin | C. Guette | P. Jézéquel | A. Patsouris

[1] Junkai Wang,et al. Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance). , 2019, Journal of the National Cancer Institute.

[2] J. Lemonnier,et al. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications , 2019, Breast Cancer Research.

[3] M. Campone,et al. iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors , 2019, Proteomics.

[4] Sanghui Park,et al. Strong Correlation of Indoleamine 2,3-Dioxygenase 1 Expression with Basal-Like Phenotype and Increased Lymphocytic Infiltration in Triple-Negative Breast Cancer , 2017, Journal of Cancer.

[5] H. Stunnenberg,et al. Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells , 2016, Immunity.

[6] Hamza Lasla,et al. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response , 2015, Breast Cancer Research.

[7] M. Campone,et al. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer , 2012, Breast Cancer Research and Treatment.